Bharat Biotech slams study that gave Covishield an advantage, says Covaxin Phase 3 data will be out in July
Days after an early study claimed that the Covishield vaccine produces more antibodies against coronavirus infection than Covaxin, the latter's manufacturer on Wednesday came out with a statement and said that the preliminary research has "a lot of flaws".
READ MORE:
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
